FDA Form 483 GlaxoSmithKline Biologicals Jan 2025
FDA inspection history in Godollo, Hungary, 2025
- 1
- Form 483
Every document, by year
- Form 483
2025: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2025One Form 483, at Godollo, Hungary.
Cited most
Across all FDA Form 483 GlaxoSmithKline Biologicals Jan 2025 observations on file
- 21 CFR 211.192Production record review1
- 21 CFR 211.80General requirements1
The complete FDA Form 483 GlaxoSmithKline Biologicals Jan 2025 file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Godollo, Hungary
One Form 483 · 2025
Latest: Form 483, Jan 31, 2025 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-01-31 | 483 Form 483 | Godollo, Hungary | — | $99 |
Investigators on these documents
About FDA Form 483 GlaxoSmithKline Biologicals Jan 2025
How many FDA Form 483s has FDA Form 483 GlaxoSmithKline Biologicals Jan 2025 received?
FDA Intel has 1 Form 483 on file for FDA Form 483 GlaxoSmithKline Biologicals Jan 2025; the most recent is dated Jan 31, 2025.
When was FDA Form 483 GlaxoSmithKline Biologicals Jan 2025 last inspected by FDA?
The most recent FDA inspection document on file for FDA Form 483 GlaxoSmithKline Biologicals Jan 2025 is a Form 483 dated Jan 31, 2025, for the site in Godollo, Hungary.
What did FDA cite at FDA Form 483 GlaxoSmithKline Biologicals Jan 2025?
The regulations cited most in the observations on file for FDA Form 483 GlaxoSmithKline Biologicals Jan 2025 are 21 CFR 211.192 (Production record review), 1 time; 21 CFR 211.80 (General requirements), 1 time.